Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study
Ben Townsend, Robert A Bermel, Heidemarie Kletzl, Oscar Bortolami et al.
Citations
3 citations
Journal
Annals of Clinical and Translational Neurology
Topics
Multiple Sclerosis Research Studies
Field-Weighted Citation Impact (FWCI)
1.27
article
Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study
Ben Townsend, Robert A Bermel, Heidemarie Kletzl, Oscar Bortolami, Susanne Clinch, Lawrence Goldstick, M Giraudon, Gurpreet Deol‐Bhullar, Derrick Robertson, James D. Bowen, Robert T. Naismith, Caroline Giacobino, Scott D. Newsome, Dusanka Zecevic, Catarina Figueiredo, Yun‐An Shen
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Annals of Clinical and Translational NeurologyVol. 11(12)
Institutions
Roche (Switzerland) (CH), Cleveland Clinic (US), Statistics Korea (KR), Johns Hopkins University (US), Washington University in St. Louis (US), University of South Florida (US), Johns Hopkins Medicine (US), IQVIA (United Kingdom) (GB), Roche (Canada) (CA), Swedish Medical Center (US), Roche (United Kingdom) (GB), University of Cincinnati (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b <scp>OCARINA</scp> I study — Ben Townsend, Robert A Bermel, et al. · Annals of Clinical and Translational Neurology (2024) | TGRS Research Map | TGRS